Latest Prescription Drugs news
Olpasiran Leads to Significant Reduction in Oxidized Phospholipids
posted February 21st
by modernClinician Editorial Team
by modernClinician Editorial Team
Anifrolumab Tied to Less Organ Damage for Patients With Lupus
posted February 20th
by modernClinician Editorial Team
by modernClinician Editorial Team
De-Escalating DAPT to Ticagrelor Monotherapy Cuts Bleeding Risk in Acute Coronary Syndrome
posted February 19th
by modernClinician Editorial Team
by modernClinician Editorial Team
Talazoparib + Enzalutamide Tied to Improved Overall Survival in Metastatic Prostate Cancer
posted February 19th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy .jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers 
Urine Cell-Free RNA Shows Promise as Biomarker for Bladder Cancer 
Pre-Prostate Biopsy MRI Use Increased From 2017 to 2026 Related Articles
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis 
1 in 3 With Lupus Take Supplements, Medications With Potential for Interactions 
2013 to 2024 Saw Decrease in Benzodiazepine Prescribing 
Polypharmacy of Prescription Medications Increased for U.S. Older Adults Monthly Specialist Briefings
Stay Connected
